Xiaojian Yang

Xijing Hospital

Papers

2

Total Citations

62

H-Index

2

About

Dr. Xiaojian Yang is a pioneering urologic surgeon whose research focuses on advancing minimally invasive techniques for complex renal cell carcinoma, particularly cases involving inferior vena cava (IVC) tumor thrombus. His major contributions center on developing and validating robot-assisted surgical approaches as safer alternatives to traditional open surgery, which carries high complication and mortality rates. In his landmark 2020 multi-institutional study (54 citations), Dr. Yang established a critical decision-making scheme for robot-assisted cavectomy versus thrombectomy in Level II IVC thrombus cases, providing surgeons with evidence-based guidelines for this challenging procedure. His 2021 case report series further demonstrated the feasibility and advantages of robot-assisted laparoscopic radical nephrectomy with IVC tumor thrombectomy, showing reduced operative trauma and improved patient outcomes compared to conventional open approaches. Dr. Yang's work has been instrumental in expanding the boundaries of robotic surgery in urologic oncology, offering patients with advanced renal cancer less invasive treatment options. His research continues to shape surgical protocols and training for managing one of urology's most technically demanding procedures.

Research Focus

Key Achievements

2
H-Index
2
Papers
62
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Cavectomy Versus Thrombectomy for Level II Inferior Vena Cava Thrombus: Decision-making Scheme and Multi-institutional Analysis
54 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: Xijing Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago